Brad Schenkel

Impact of epoetin alfa on clinical end points in patients with chronic renal failure: A meta-analysis

Michael Jones, Lloyd S. Ibels, Brad Schenkel et al. · Kidney International · 2004 · 664 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +14

Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan

Tsen‐Fang Tsai, Ting-Shun Wang, Sheng-Tzu Hung et al. · Journal of Dermatological Science · 2011 · 323 citations

Medicine, Clinical Sciences, Dermatology +10

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

Richard G. Langley, Steven R. Feldman, Chenglong Han et al. · Journal of the American Academy of Dermatology · 2010 · 216 citations

Medicine, Dermatology, Pharmacotherapy +12

Long-term efficacy of ustekinumab in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial through up to 3 years

Alexa B. Kimball, Ken Gordon, S. Fakharzadeh et al. · British Journal of Dermatology · 2012 · 131 citations

Medicine, Dermatology, Pharmacotherapy +13

Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial

Mark Lebwohl, Kim Papp, Chenglong Han et al. · British Journal of Dermatology · 2009 · 98 citations

Medicine, Dermatology, Pharmacotherapy +11